Torque teno virus kinetics after lung transplantation and its association to immunosuppression schemes and to clinical complications

Peter Jaksch (Vienna, Austria), Irene Goerzer, Peter Jaksch, Tamara Seitz, Walter Klepetko, Elisabteh Puchhammer

Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Session: Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Session type: Poster Discussion
Number: 1795
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Peter Jaksch (Vienna, Austria), Irene Goerzer, Peter Jaksch, Tamara Seitz, Walter Klepetko, Elisabteh Puchhammer. Torque teno virus kinetics after lung transplantation and its association to immunosuppression schemes and to clinical complications. Eur Respir J 2015; 46: Suppl. 59, 1795

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early and late viral infections after lung transplantation
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015

Respiratory syncytial viral infections in lung transplant recipients: Treatment with aerolised ribavirin
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Viral infection land lung function decline following lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

Hypogammaglobulinemia in lung transplant candidates
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016

A single-season prospective study of respiratory viral infections in lung transplant recipients
Source: Eur Respir J 2006; 28: 131-137
Year: 2006



Human lung transplantation: cytomegaloviral and rhinoviral co-infection is a distinct risk for acute rejection
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016


Clinical utility of quantitative cytomegalovirus detection in bronchial washing fluid in patients with hematologic malignancies
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015

Cytomegalovirus as predisposing agent to respiratory infections in heart transplant patients
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013


Frequency and characteristics of prolonged viral shedding of influenza A/H1N1 virus in lung transplant recipients
Source: Annual Congress 2011 - Lung transplantation
Year: 2011

Evaluation of two prognostic scoring systems for respiratory syncytial virus infection in a French multicentre cohort of allogeneic hematopoietic stem cell transplant recipients
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Year: 2021


Oral human serum immunoglobulin for norovirus diarrhea in pulmonary transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013


Utility of biomarkers in the management of respiratory diseases in hematopoietic stem cell transplant
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013


Incidence of viral infections in patients with lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

NFkB location in T-cells is promising to monitor immunosuppression after lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014

Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching
Source: Eur Respir J 2005; 26: Suppl. 49, 636s
Year: 2005

Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Ribavirin therapy for respiratory syncitial virus infection after lung transplantation
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


Pulmonary viral infection in hematologic patients with and without stemcell transplantation
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011

Associations of Epstein-Barr virus and Cytomegalovirus with school-age lung function and asthma.
Source: International Congress 2019 – Aetiology and management of childhood respiratory infections, primary ciliary dyskinesia and asthma
Year: 2019